With more treatment options emerging for human immunodeficiency virus (HIV) infection, the policy of reporting HIV-infection, the policy of reporting HIV-infected individuals by name merits reevaluation.
This paper reviews the benefits and risks of name reporting of persons infected with HIV.
Public health departments have linked name reporting with medical referrals, risk reduction counseling, and partner notification programs.
Yet some studies indicate that people are less likely to be tested for HIV infection when name reporting is implemented.
Wheather name reporting actually improves individual or public health, therefore justifying the increased risk of loss of confidentiality and possible reduced testing rates, remains unknown.
The lack of health outcome data on name reporting allows beliefs rather than facts to dominate debate about this policy.
Before this practice is more widely adopted, a determination should be made as to whether the potential benefits of name reporting outweight the risks.
Mots-clés Pascal : SIDA, Virose, Infection, Confidentialité, Epidémiologie, Evaluation, Risque, Bénéfice, Homme, Article synthèse, Immunopathologie, Immunodéficit
Mots-clés Pascal anglais : AIDS, Viral disease, Infection, Confidentiality, Epidemiology, Evaluation, Risk, Profit, Human, Review, Immunopathology, Immune deficiency
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0290254
Code Inist : 002B06D01. Création : 27/11/1998.